Sbi Securities Co., Ltd. Inmune Bio, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.9 Trillion
- Q3 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 5,548 shares of INMB stock, worth $8,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,548
Previous 1,633
239.74%
Holding current value
$8,044
Previous $3.77 Million
204.45%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding INMB
# of Institutions
84Shares Held
5.36MCall Options Held
310KPut Options Held
371K-
Vanguard Group Inc Valley Forge, PA876KShares$1.27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.18 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$864,73945.87% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$680,6880.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$535,6850.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $26M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...